Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.
Cost Eff Resour Alloc
; 16: 17, 2018.
Article
in En
| MEDLINE
| ID: mdl-29773969
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Language:
En
Journal:
Cost Eff Resour Alloc
Year:
2018
Document type:
Article